PlateletDoc Profile Banner
Dr. Jeffrey Berger Profile
Dr. Jeffrey Berger

@PlateletDoc

Followers
929
Following
1K
Media
54
Statuses
602

prevention focused cardiologist; platelet scientist; thrombosis & vascular medicine specialist; proud husband & father of fantastic girls; @NYUCVDPrevent

Joined March 2018
Don't wanna be here? Send us removal request.
@PlateletDoc
Dr. Jeffrey Berger
1 year
Finally! A circulating platelet genetic signature (PRESS)🔥that predicts platelet hyperreactivity and increased cardiovascular risk. Collaborative science is awesome!! @TessaJBarrett @NSmilowitzMD @NYUCVDPrevent @NYULHCVRC https://t.co/LMZLuMjABq
7
10
58
@NYUCVDPrevent
NYU CVD Prevention
10 days
New findings suggest 7,000 steps may be enough to reduce your risk of heart disease & stroke. Focus on moving more & sitting less, & activities you love, like gardening or dancing says our Director of Cardiovascular Fitness & Nutrition, Dr. Sean Heffron. https://t.co/rBI3ZJi584
Tweet card summary image
healio.com
Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not based on evidence, and other lifestyle factors should be considered.A recent...
1
2
5
@PlateletDoc
Dr. Jeffrey Berger
10 days
Platelet reactivity expression score (PRESS) is increased in #diabetes and identifies pts at higher risk of cardiovascular events @JoshuaBeckmanMD @NYULHCVRC
Tweet card summary image
ashpublications.org
TO THE EDITOR:
1
2
8
@NYUCVDPrevent
NYU CVD Prevention
2 months
📣New Research Alert! Patients with both PAD and #diabetes are more likely to have hyperreactive #platelets, as measured by the PRESS genetic signature, putting them at higher risk for cardiovascular events. Open Access: https://t.co/n154wfPA0Z
0
3
6
@NYUCVDPrevent
NYU CVD Prevention
4 months
Prevention Center’s Annual Retreat! Faculty and staff reflected on the past year, reviewing our core missions in education, clinical care, and research. We’re energized to advance our mission and impact!! #hearthealth
1
4
12
@NYUCVDPrevent
NYU CVD Prevention
4 months
We’re excited to welcome Dr. Mark Steuerwald as our newest Preventive Cardiology Fellow—the 16th in our program’s history. Congratulations and welcome!
0
6
17
@lipiddoc
Dr. James Underberg
4 months
Very excited to welcome our new Fellow! #Lipids #LipidologistInTraining 16 Lipid specialists so far , #17 on the way ! As my good friend and colleague @DrLipid always says- Happy Lipiding ! @NYUCVDPrevent @nationallipid
@NYUCVDPrevent
NYU CVD Prevention
4 months
We’re excited to welcome Dr. Mark Steuerwald as our newest Preventive Cardiology Fellow—the 16th in our program’s history. Congratulations and welcome!
1
3
25
@NYUDocs
Doctor Radio
5 months
Do you have questions about cholesterol, high blood pressure or another cardiology question? Medical Grand Rounds is LIVE. @MarkPochapin is talking with @PlateletDocCall them at 877-698-3627 https://t.co/vuGRUcZZvE
0
2
6
@PlateletDoc
Dr. Jeffrey Berger
6 months
Striking relationship between preoperative #platelet count and perio-operative cardiovascular events - @NYUCVDPrevent @NYULH_DeptofMed @JTHjournal
0
0
4
@PlateletDoc
Dr. Jeffrey Berger
6 months
Great collaboration with @BredellaMD showcasing the importance of Opportunistic Imaging!! #AI can identify heart disease and cardiovascular risk from any clinical abdominal CT scan - This is the future of medicine @NYUCVDPrevent @nyulangone @CTSINYULH
0
5
11
@PlateletDoc
Dr. Jeffrey Berger
6 months
0
1
2
@PlateletDoc
Dr. Jeffrey Berger
6 months
Excess cardiovascular risk in patients w/ low functional capacity is mediated, in part, by increased platelet activity @tessabarrett @NYUCVDPrevent @nyugrossman @NYULH_DeptofMed
2
2
7
@NYUCVDPrevent
NYU CVD Prevention
7 months
Register for the 5th Annual #CardioRheum symposium and get free access to Medscape’s 1 hour mini-symposium: ‘Race Against Inflammation: ASCVD & #CKD Risk Reduction Insights.’ Join in-person or virtually—don’t miss the main event + bonus content! Sign up: https://t.co/SB3SAaQyeO
0
7
10
@theheartorg
theheartorg | Medscape
7 months
🎯 Register for #CardioRheum & get FREE access to Medscape’s mini symposium: Race Against Inflammation: ASCVD and CKD Risk Reduction Insights. 📅 April 25 | In-person or virtual 🔗 https://t.co/8Hvqjaz7vQ 👩‍⚕️ @NYUCVDPrevent @garshick @Bweber04
0
6
16
@adambermanmd
Adam Berman, MD MPH
7 months
Incredibly excited to publish our NOTIFY-LVH randomized trial of 648 patients within the @MassGenBrigham system, highlighting the potential of leveraging preexisting cardiovascular data to improve the detection and treatment of chronic cardiovascular conditions.
4
16
76
@NYUCVDPrevent
NYU CVD Prevention
9 months
#HeartMonth is the perfect time to swap out the 'beige diet' for a vibrant, nutrient-packed plate! Cardiologist Sean Heffron, MD, and registered dietitian Heather Hodson, RDN, share tips with @nypost on colorful foods to boost #hearthealth! https://t.co/3rlxcNGQBz
0
5
11
@nypost
New York Post
9 months
In the latest edition of "Best Medicine," we spoke to Dr. Sean P. Heffron and Heather Hodson Py about ditching the 'beige diet'. https://t.co/U53tTity0g #sponsored @nyulangone
3
3
21
@CarineHamo
Dr. Carine Hamo
9 months
Out now! We found that greater 🔥 cardiometabolic comorbidity burden (obesity, diabetes, hyperlipidemia) is asstd with🩸increased platelet size and immaturity and dysregulated pathways 📊related to metabolism and immaturity. https://t.co/gwXb8nkjS1
0
3
7
@CarineHamo
Dr. Carine Hamo
10 months
Out today! 📰We found that among ~16K HF 🫀patients, 35% had at least 1 severely ⬆️uncontrolled cardiometabolic comorbidity (HTN, DM, obesity) and this was associated with significantly higher 📈risk of all-cause and HF-hospitalization🏥. https://t.co/aI5udAkpiP
2
4
22
@PlateletDoc
Dr. Jeffrey Berger
10 months
Congratulations Dr Akinlonu for this #AHA SFRN funded study investigating variation in Lp(a) response to potent lipid lowering therapy @AHAScience @NYULHCVRC @NYUCVDPrevent
0
1
8
@PlateletDoc
Dr. Jeffrey Berger
11 months
Cardiology and oncology collaborative review describing link between thrombo-inflammation and androgen suppression with cardiovascular risk in patients with #prostatecancer https://t.co/WKE2abLNJl @nyugrossman @NYUCVDPrevent
0
1
5